Body Mass Index: Do You Know Yours? ( rward. Source-Newswise SM ...)

(Date:10/8/2008)... HIV-test-kit.com is a new site aimed a....V. from the comfort and privacy of their own home... issue. It is hoped that through home tests more p...he AIDS virus. , New York...eople are getting more used to getting instant res...

(Date:10/8/2008)... Drug Information Association (DIA) wil...-7; Ottawa, Ontario, Canada) to discuss a number o...aceutical industry, health academia, and the healt... PA (PRWEB) October 8, 2008 -- The http://www.diah... host the http://www.diahome.org/diahome/FlagshipM...

(Date:10/8/2008)... AccurateAnswers™ support program...es for http://www.appointment-plus.com [online s... Scottsdale, AZ (PRWEB) October 8, 2008 -- ... scheduling software, continues to expand its soft...n most "software as a service" providers...

(Date:10/8/2008)... Juva Skin & Laser Center is well e...kin treatments in New York City. The facility is l...e, one of the latest skin resurfacing treatments t...e laser equipment. , New ...urgery and laser treatment industry is in the mids...

Breaking Medicine News(10 mins):Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2 Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2 Health News:Appointment-Plus Continues Innovation With Technical Support Program 2 Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2

[0] HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device [0] DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress [0] Appointment-Plus Continues Innovation With Technical Support Program [0] Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System

...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...

... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...

...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...

...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...

Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2 Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3

Good News For Those Of You Suffering From Rheumatoid Arthritis Ankle Fracture Surgery – Diabetics fare worse than non-diabetics Researchers Bring New Insight To Asthma And SABA Fills Breast Cancer’s Does Not Discriminate – Rich and Famous Who have had Breast Cancer and Surviv

(Date:10/7/2008)...lts of FLEXX Trial Presented at the Osteoarthritis...ess, PARSIPPANY, N.J., Oct. 7 /- Fer...ts from the FLEXX Trial of Osteoarthritis of the,K...te), a highly pure,non-avian high molecular weight...is superior to intra-articular saline (IA-saline) ...

(Date:10/7/2008)... COLLINS, Colo., Oct. 7 /- A study pu... embryonic stem cell self-renewal,reported that I...ecombinant,human serum albumin) was an effective r...ure., The article entitled, "The ground state of ...researchers used Cellastim as a recombinant,albumi...

(Date:10/7/2008)...ent, Prospective Randomized Placebo-Controlled Pha...nt Improved Overall Survival., MOUNTAIN VIEW, Cal...eutics has now evaluated the mature Phase II data ...date PROSTVAC(TM) that had been,obtained as part o...al,Cancer Institute (NCI) in the US., The results...

(Date:10/6/2008)...O and CHIPPENHAM, England, October 7 /PRNewswire-F... Mothers Index: 4565) and Vectura,Group plc ("Vect...studies,evaluating the efficacy, safety and tolera...of the European Respiratory Society (ERS) in Berli...rronium bromide), a novel,inhaled long-acting musc...

Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2 Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3 Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4 BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2 BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3 BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4 NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2 NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3 NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4 NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5 North Americas northernmost lake affected by global warming 571 1 North Americas northernmost lake affected by global warming 571 2 TIGroup Names Dennis M Smith as Chief Financial Officer 2083 1 TIGroup Names Dennis M Smith as Chief Financial Officer 2083 2 TIGroup Names Dennis M Smith as Chief Financial Officer 2083 3 TIGroup Names Dennis M Smith as Chief Financial Officer 2083 4 Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 1 Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 2 Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 1 Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 2

[0] Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period [1] InVitria's Cellastim Showcased in Nature Article [1] BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine [0] NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...lood Glucose,Control and Progressive Weight Loss -... Amylin,Pharmaceuticals, Inc. and Eli Lilly and Co...owed BYETTA(R) (exenatide) injection,sustained imp...ight,loss through three and a half years of therap...vements in cardiovascular risk,factors in people w...

...2007--Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...ovir,DF) 300 mg as a potential treatment for chron...ary efficacy endpoint. The data show,that Viread i...al,drug Hepsera(R) (adefovir dipivoxil) among pati...

Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2 Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3 Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4 Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5 Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6 Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2 Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3 Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4 Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5 Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6

Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint

...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...

EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.

The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t

The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co

Medicine Products:

DHEA-S RIA Test EL-RF-IgM Immunosimplicity® Is RF Test Kit SYNCHRON CX® 4 Delta

( rward. Source-Newswise SM ...)Body Mass Index: Do You Know Yours?,Health